Wan-Chih Su

Wan-Chih Su is a Principal Scientist at Genentech, where they focus on analytical chemistry, biophysics, and biocompatible synthetic materials. They previously worked as a Bioprocess Analytical Scientist at Sanofi Genzyme, developing assays for gene therapy samples, and as a Therapeutics Intern at 23andMe, where they contributed to drug discovery through pharmacokinetics and biomarker analysis. Wan-Chih's extensive research background includes a postdoctoral position at the University of California, Davis, where they explored nano-formulation delivery platforms and studied neurodegenerative disease mechanisms. They are currently pursuing a PhD in Chemistry at the University of California, Davis, while holding a Bachelor of Science in Biological Science and Technology from National Chiao Tung University.